Literature DB >> 30639959

Hearing loss and quality of life.

Jerry L Punch1, Rose Hitt2, Sandi W Smith2.   

Abstract

OBJECTIVE: We sought to identify multidimensional factors associated with health-related quality of life (HRQoL) for use in developing an inventory in which HRQoL is a core concept in evaluating the impact of hearing loss and the efficacy of rehabilitative interventions.
METHOD: A qualitative approach was used in which we posed two major questions to a focus group consisting of eight adults with self-reported, bilateral sensorineural hearing loss of varying degrees. In essence, those questions were: (1) How do you define quality of life?, and (2) Can you describe specific incidents in your everyday life in which your hearing loss has impacted your quality of life? The discussion was embedded within a framework that utilized a modification of the Critical Incident Technique (CIT). We used well-established analytic techniques to translate the data into unitized thought units, which we coded into meaningful categories. Response frequency was used to determine the salience of responses in addressing the research questions.
RESULTS: Participants defined QoL in terms of a number of primary dimensions, most of which were directly or indirectly associated with specific recalled incidents in which those dimensions have played a notable role in contributing to their QoL.
CONCLUSIONS: The use of well-established methods to gather and analyze qualitative data generated by self-report techniques offers a promising direction for developing a standardized inventory for identifying the factors that impact QoL for persons with hearing loss and for evaluating the success of intervention strategies aimed at improving their HRQoL.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Critical Incident Technique; Hearing impairment; Hearing loss; Qualitative data; Quality of life

Mesh:

Year:  2019        PMID: 30639959     DOI: 10.1016/j.jcomdis.2019.01.001

Source DB:  PubMed          Journal:  J Commun Disord        ISSN: 0021-9924            Impact factor:   2.288


  6 in total

1.  Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease.

Authors:  Connie M Sears; Amee D Azad; Linus Amarikwa; Brandon H Pham; Clara J Men; Daniel N Kaplan; Jocelyn Liu; Andrew R Hoffman; Austin Swanson; Jennifer Alyono; Jennifer Y Lee; Chrysoula Dosiou; Andrea L Kossler
Journal:  Am J Ophthalmol       Date:  2022-02-25       Impact factor: 5.488

Review 2.  Recent advancements in understanding the role of epigenetics in the auditory system.

Authors:  Rahul Mittal; Nicole Bencie; George Liu; Nicolas Eshraghi; Eric Nisenbaum; Susan H Blanton; Denise Yan; Jeenu Mittal; Christine T Dinh; Juan I Young; Feng Gong; Xue Zhong Liu
Journal:  Gene       Date:  2020-07-29       Impact factor: 3.688

3.  Hearing Loss in Cancer Patients with Skull Base Tumors Undergoing Pencil Beam Scanning Proton Therapy: A Retrospective Cohort Study.

Authors:  Barbara Bachtiary; Dorothe Veraguth; Nicolaas Roos; Flurin Pfiffner; Dominic Leiser; Alessia Pica; Marc Walser; Stefanie von Felten; Damien C Weber
Journal:  Cancers (Basel)       Date:  2022-08-09       Impact factor: 6.575

4.  Urinary pyrethroid metabolite and hearing threshold shifts of adults in the United States: A cross-sectional study.

Authors:  Lili Long; Yuedi Tang
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

5.  Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.

Authors:  Heather L Thompson; Ann Blanton; Barbara Franklin; Vanessa L Merker; Kevin H Franck; D Bradley Welling
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

Review 6.  Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy.

Authors:  David M Baguley; Pattarawadee Prayuenyong
Journal:  Cancer Chemother Pharmacol       Date:  2019-12-21       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.